tradingkey.logo

Scisparc Ltd

SPRC
View Detailed Chart

5.826USD

+0.156+2.76%
Market hours ETQuotes delayed by 15 min
291.08KMarket Cap
LossP/E TTM

Scisparc Ltd

5.826

+0.156+2.76%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.76%

5 Days

-19.75%

1 Month

-11.72%

6 Months

+1217.87%

Year to Date

+1518.42%

1 Year

+1474.68%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(2)
Buy(3)
Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.922
Neutral
RSI(14)
50.793
Neutral
STOCH(KDJ)(9,3,3)
9.582
Oversold
ATR(14)
0.676
Low Volatility
CCI(14)
-169.920
Sell
Williams %R
89.844
Oversold
TRIX(12,20)
3.868
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
6.336
Sell
MA10
7.081
Sell
MA20
7.127
Sell
MA50
3.163
Buy
MA100
1.737
Buy
MA200
1.056
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Ticker SymbolSPRC
CompanyScisparc Ltd
CEOMr. Amitay Weiss
Websitehttps://scisparc.com/
KeyAI